Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  KKR & Co. L.P.    KKR

News SummaryMost relevantAll newsSector news 

KKR Confirms $3.74 Billion Deal to Buy Gardner Denver

share with twitter share with LinkedIn share with facebook
share via e-mail
03/08/2013 | 02:26am CET

Gardner Denver Inc. (>> Gardner Denver, Inc.) and Kohlberg Kravis Roberts & Co. confirmed the industrial-pumps manufacturer has agreed to be acquired for roughly $3.74 billion.

The New York private-equity firm will pay $76 for each Gardner Denver share, a 2.9% premium to Thursday's close. Shares were recently trading 1.4% higher at $74.91 premarket. The stock has climbed 7.8% since the start of the year.

The deal values Gardner Denver at about $3.9 billion, including the assumption of debt.

KKR had bid $75 a share for the Wayne, Pa.-based company in February and increased the offer after Gardner Denver sought a higher price.

For KKR, the deal would mark the buyout firm's third purchase in the industrials space in the past few years. KKR agreed in April 2011 to acquire Capsugel, a unit of pharmaceutical giant Pfizer Inc. (>> Pfizer Inc.) that makes drugs in capsule form. Later that year, KKR agreed to acquire Capital Safety Inc., a large provider of safety products and equipment for construction and other workers.

KKR ended up being the only serious suitor for Gardner Denver in an up-and-down sales process that dragged on in recent months.

Gardner Denver, which employs about 6,400 people and posted sales of about $2.4 billion last year, pursued a deal with rival SPX Corp. (>> SPX Corporation) late last year after garnering interest from a number of private-equity firms. SPX offered $4 billion for the company but later dropped the bid amid negative reactions from shareholders.

Write to Melodie Warner at melodie.warner@dowjones.com

Order free Annual Report for Gardner Denver Inc.

Visit http://djnewswires.ar.wilink.com/?link=GDI or call 1-888-301-0513

Stocks mentioned in the article : Gardner Denver, Inc., SPX Corporation, Pfizer Inc.
share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on KKR & CO. L.P.
12/01 KKR L P : Capitalizes Real Estate Finance Trust Inc.
11/30 KKR & CO. L.P. : Blog Coverage KKR Set to Become Majority Shareholder of Hilding..
11/29 KKR L P : Acquires Arle's Stake in Hilding Anders
11/29 KKR : Acquires Arle’s Stake in Hilding Anders
11/28 KKR : Credit Continues to Extend Sponsor-Led Financing and Direct Lending Activi..
11/28 KKR L P : Sino-Ocean and KKR Invest in Capital Juda
11/22 Nissan to sell stake in top supplier Calsonic Kansei to U.S. fund
11/22 KKR announces tender offer for the acquisition of Calsonic Kansei - Nissan ag..
11/22 KKR L P : Announces Tender Offer for the Acquisition of Calsonic Kansei Nissan A..
11/21 KKR : Capitalizes KKR : Real Estate Finance Trust Inc.
More news
Sector news : Investment Management
12/02DJMorgan Stanley Toughens Pay Hurdles for Brokers
12/02 Trump creates business advisory council stacked with CEOs
12/01 CREDIT SUISSE : Swiss spin-off faces same capital rules as group
11/29DJAMP : Makes Changes to Senior Leadership
11/28 Britain's JD Sports buys Go Outdoors for 112 million pounds
More sector news : Investment Management
News from SeekingAlpha
11/30 A Cold Shoulder For Cloud Peak - Cramer's Lightning Round (11/29/16)
11/29 Financial Sector Analysts See BGC Partners As Top Dog For November Gains
11/23 KKR Is Ready For Takeoff
11/22 KKR launches $4.5B offer for Calsonic Kansei
11/14 E&P Private Equity Opens The Capital Floodgates - Good Or Bad For Public Inve..
Financials ($)
Sales 2016 1 089 M
EBIT 2016 629 M
Net income 2016 260 M
Debt 2016 -
Yield 2016 4,13%
P/E ratio 2016 27,64
P/E ratio 2017 10,24
Capi. / Sales 2016 11,5x
Capi. / Sales 2017 10,5x
Capitalization 12 480 M
More Financials
Chart KKR & CO. L.P.
Duration : Period :
KKR & Co. L.P. Technical Analysis Chart | KKR | US48248M1027 | 4-Traders
Full-screen chart
Technical analysis trends KKR & CO. L.P.
Short TermMid-TermLong Term
Technical analysis
Income Statement Evolution
More Financials
Mean consensus OUTPERFORM
Number of Analysts 14
Average target price 18,5 $
Spread / Average Target 20%
Consensus details
EPS Revisions
More Estimates Revisions
Henry R. Kravis Co-Chairman & Co-Chief Executive Officer
George Rosenberg Roberts Co-Chairman & Co-Chief Executive Officer
William Joseph Janetschek Chief Financial Officer
Joseph A. Grundfest Independent Director
Robert W. Scully Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
KKR & CO. L.P.-0.71%12 480
LEGAL & GENERAL GROUP ..-9.52%18 376
T. ROWE PRICE GROUP IN..5.71%18 374
More Results